Your browser doesn't support javascript.
Prevalence of molecular and serological tests of the new coronavirus (SARS-CoV-2) in Carlos Chagas laboratory - Sabin group in Cuiabá.
Paula, Cristiane Coimbra de; Shimoya-Bittencourt, Walkiria; Passos, João Pedro Castoldo; Paula, Caroline Aquino Vieira De Lamare; Arunachalam, Karuppusamy; Fontes, Cor Jesus Fernandes; Oliveira, Ruberlei Godinho de.
  • Paula CC; Centro Universitário de Várzea Grande - Varzea Grande (MT), Brazil.
  • Shimoya-Bittencourt W; Laboratório Carlos Chagas - Grupo Sabin - Cuiabá (MT), Brazil.
  • Passos JPC; Centro Universitário de Várzea Grande - Varzea Grande (MT), Brazil.
  • Paula CAVL; Centro Universitário de Várzea Grande - Varzea Grande (MT), Brazil.
  • Arunachalam K; Scan Rastreamento em Medicina Diagnóstica - Cuiabá (MT), Brazil.
  • Fontes CJF; Chinese Academy of Sciences, Kunming Institute of Botany, Key Laboratory of Economic Plants and Biotechnology and the Yunnan Key Laboratory for Wild Plant Resources - Kunming, China.
  • Oliveira RG; Universidade Federal de Mato Grosso, Hospital Universitário Júlio Müller - Cuiabá (MT), Brazil.
Rev Assoc Med Bras (1992) ; 68(3): 344-350, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-2114224
ABSTRACT

BACKGROUND:

Coronavirus disease 2019, which is caused by the new severe acute respiratory syndrome coronavirus 2, became a pandemic in 2020 with a mortality rate of 2% and high transmissibility, thus making studies with an epidemiological profile essential.

OBJECTIVES:

The aim of this study was to characterize the population that performed the severe acute respiratory syndrome coronavirus 2 molecular and serological tests in Carlos Chagas Laboratory - Sabin Group in Cuiabá.

METHODS:

A retrospective cross-sectional study was carried out with all the samples collected from nasal swab tested by RT-PCR and serological for severe acute respiratory syndrome coronavirus 2 IgM/IgG from the population served between April and December 2020.

FINDINGS:

In the analysis period, 23,631 PCR-coronavirus disease 2019 examinations were registered. Of this total number of cases, 7,649 (32.37%) tested positive, while 15,982 (66.31%) did not detect viral RNA and 374 of the results as undetermined. The peak of positive RT-PCR performed in July (n=5,878), with 35.65% (n=2,096). A total of 8,884 tests were performed on serological test SOROVID-19, with a peak of 1,169 (57.16%) of the positive tests for severe acute respiratory syndrome coronavirus 2 in July. MAIN

CONCLUSIONS:

Molecular positivity and serological tests, both peaked in July 2020, were mostly present in women aged 20-59 years, characterizing Cuiabá as the epicenter of the Midwest region in this period due to the high rate of transmissibility of severe acute respiratory syndrome coronavirus 2.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Randomized controlled trials Limits: Female / Humans Language: English Journal: Rev Assoc Med Bras (1992) Year: 2022 Document Type: Article Affiliation country: 1806-9282.20210769

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Randomized controlled trials Limits: Female / Humans Language: English Journal: Rev Assoc Med Bras (1992) Year: 2022 Document Type: Article Affiliation country: 1806-9282.20210769